ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryZurichEvax AG
Evax AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of EVAX AG is the development of therapeutic vaccines for the treatment of chronic diseases in horses, particularly allergies and respiratory diseases, by transferring human care standards to horses.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered5
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.9/5

Evax AG

Horse vaccines
Vaccines against summer eczema and other chronic conditions, developed for allergies and respiratory diseases in horses; clinically tested in studies with horses.
Diagnostics for equine summer eczema
Molecular biological analysis of skin biopsies for diagnosing summer eczema; qPCR-based gene quantification, expert evaluation, offered for veterinarians.
Care products for horses
Care products for horses, available in the Swiss and international shop; with every purchase, further development of therapies is supported.
Research on equine allergies and respiratory diseases
Basic research on immunology and allergies in horses, focusing on disease mechanisms, laboratory work, and derivation of therapeutic approaches.
Clinical trials for horses
Clinical trials with vaccines in horses, currently in multiple indications and available only for horses from Switzerland.
Trust & reputation

ranQ Trust Score of Evax AG: 3.9 out of 5.0

Trust Score3.9/ 5.0

High

x

Data basis 96% · As of October 2026

Evax AG scores 63.5 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.77.424%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.52.910%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.35.08%
Evax AG scores 63.4 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.39.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Evax AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
Evax AG scores 31.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.31.44%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Evax AG reaches a ranQ Trust Score of 3.9 out of 5.0 — rated «High». The rating draws, among other things, on 4.9 out of 5 stars from 7 customer reviews. The data basis is 96%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
4.9
of 5

Aggregated from 7 reviews across all connected sources

Sources
GGoogle4.97
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Knowledge

No knowledge articles yet

Once Evax AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Evax AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Evax AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Evax AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Dufourstrasse 49
8008 Zurich

At a glance

Legal form
Corporation
UID
CHE-419.698.976
Founded
2024 · 2 years
Last commercial register change
August 17, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    TP
    Takeda Pharmaceuticals International AG
    Glattpark (Opfikon)
    MT
    Memo Therapeutics AG
    Schlieren
    FH
    Future Health Pharma GmbH
    Wetzikon Zh 1
    MA
    Mabylon AG
    Schlieren
    PA
    Pfizer AG
    Zurich
    DG
    DeepVax GmbH
    Rämismühle
    VA
    Vaccentis AG
    Zurich
    NN
    Novo Nordisk Health Care AG
    Zürich